Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-0366

Known as: MK 366, MK 0366, MK366 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Norfloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Highly Cited
1983
Highly Cited
1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… Expand
  • table 1
1983
1983
Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
Norfloxacin (MK-0366) is a new antibacterial agent, closely related to nalidixic acid, with broad spectrum activity against Gram… Expand
1983
1983
The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
Norfloxacin (MK0366) displayed appreciable activity against the great majority of Gram-negative and Gram-positive bacteria. The… Expand
1983
1983
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
  • R. Jones, A. Barry
  • Diagnostic microbiology and infectious disease
  • 1983
    • Corpus ID: 30310049
Norfloxacin is a new organic acid antimicrobic with an expanded spectrum that includes Staphylococcus spp, most Pseudomonas spp… Expand
Highly Cited
1982
Highly Cited
1982
In vitro antibacterial activity of norfloxacin (MK-0366).
The in vitro activity of norfloxacin (MK-0366) compared with that of beta-lactam antibiotics and, where appropriate of gentamicin… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
1982
Highly Cited
1982
Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
A high-performance liquid chromatographic method for the analysis of norfloxacin (MK-366) [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
1982
1982
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia… Expand
  • figure 1
Highly Cited
1982
Highly Cited
1982
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid… Expand
  • table 1
1981
1981
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… Expand
  • table 1
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE